Cases & Deals

  • Home
  • Practices
  • Abbott obtains tax advice in connection with its $250 million acquisition of OptiMedica Corporation

Share

Abbott obtains tax advice in connection with its $250 million acquisition of OptiMedica Corporation

August 2013

Client(s) Abbott Laboratories

Jones Day advised Abbott Laboratories on tax issues in connection with its $250 million acquisition of OptiMedica Corporation, a privately-held, Silicon Valley-based ophthalmic device company.

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.